2018 annual financial data
Chemomab Therapeutics 2018 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was 12,658,000 USD and net income was 13,279,000 USD.
Operating cash flow was -14,176,786 USD.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- 12,658,000 USD
- Net income
- 13,279,000 USD
- Operating cash flow
- -14,176,786 USD